A practitioner touted the benefits of using a contingency management-based app to help treat patients with substance abuse disorder and called for more providers to consider app-based treatments that are approved by FDA, speaking at a DTX West conference on digital therapeutics. Audrey Kern, global medical director of Pear Therapeutics, discussed real-world examples of app-based treatment with digital therapeutics prescriber Adam Rubenstein, a private practitioner in Chicago. Rubenstein described himself as a “patient-focused” practitioner who serves as a primary care...